Skip to content
counter-narrative

Bitcoin hits $64K while its biggest corporate advocates quietly step back

Strategy raised $334 million last week and bought zero satoshis, channeling $149 million into a dollar reserve instead. As IREN abandons mining for AI cloud and a Nasdaq healthcare company dumps its entire Bitcoin stack to cover a $3.41 million deficit, corporate conviction is running colder than the price chart suggests.

Bitcoin hits $64K while its biggest corporate advocates quietly step back
Methodology
Learn more

Original analysis, verified sources, real-world experience

Bitcoin crossed $64,000 last week on 2% daily gains, moving in tandem with gold as US stocks wobbled on fresh geopolitical noise. If you read only the price feed, the setup looked clean: macro tailwinds, institutional narrative intact, all systems go. Read the corporate filings and a different picture takes shape.

Strategy's pause

Cointelegraph and Decrypt both confirmed it: Strategy sold 3.46 million MSTR shares last week, collected $333.7 million, and left its 840,447 BTC position untouched. Of the proceeds, $149.1 million went into a dollar reserve now sitting at $4.8 billion, $52.4 million covered STRC dividends, and $132.2 million bought back preferred shares.

The company's average purchase price is $75,385 per BTC. At $64,000 spot, that's a paper loss of roughly $9.5 billion across the stack. We are not suggesting Strategy is abandoning its thesis – three weeks of paused buying does not erase years of accumulation. But the specific decision to build a near-$5 billion fiat reserve while simultaneously promoting a Bitcoin-treasury playbook to other corporates deserves honest attention. The loudest advocate for corporate Bitcoin adoption is currently one of the largest dollar hoarders in the space.

The bullish reading is that Strategy is preserving capital to deploy at a better entry. That is plausible. The bearish reading is that even Strategy finds the current risk/reward less compelling than its rhetoric implies.

The miner retreat

Mining companies are telling a parallel story. The Block reported that CleanSpark, BitFuFu, and Canaan all saw Bitcoin production slip again in July. BitFuFu is down more than 50% year to date, Canaan more than 70%. CleanSpark's 6.4% gain looks like survival rather than a thesis win.

IREN is making the sharpest pivot. The Block reported the company is targeting 480 MW of AI cloud capacity in 2026 and 1.2 gigawatts by 2027 under a $9.7 billion Microsoft deal – an explicit pivot away from Bitcoin mining. When infrastructure operators who built their business around block rewards decide their best capital allocation is renting compute to Microsoft, that is a structural signal about mining economics, not just one company's strategy shift.

The cautionary case

The most pointed example arrived from an unexpected corner. CryptoSlate reported that a Nasdaq-listed healthcare data company, which had publicly promised Bitcoin would "safeguard its future," sold its entire Bitcoin position after reporting a $3.41 million working-capital deficit. Equity issuance was the only disclosed funding path. The Bitcoin went first.

This is a specific failure mode that corporate Bitcoin advocates rarely address: treasury Bitcoin held by operationally weak companies becomes a liquidity backstop, not a long-term reserve. When the income statement breaks, the asset disappears regardless of conviction. A $3.41 million hole was enough to zero out the position entirely.

Protocol risk in the background

On the development side, CryptoSlate noted that Bitcoin Core's nearing feature freeze is complicated by rebase conflicts affecting at least one pending proposal around unencrypted node connections. The October timeline is not at immediate risk, but the merge-conflict backlog mixes feature proposals, bugs, and release administration in ways that make clean prioritization difficult. This is not a crisis; Bitcoin Core has navigated development queues before. It is background noise that retail participants rarely price.

Meanwhile, a separate CryptoSlate report detailed a data breach at an unnamed Bitcoin purchase platform affecting more than 250,000 customers, with Bitcoin buys suspended and the number of affected users undisclosed. Infrastructure security remains a genuine friction point for retail adoption.

The honest balance

The price move to $64,000 is real. Gold gained alongside it, oil absorbed geopolitical noise around US-Iran rhetoric without collapsing, and BTC's 2% daily move was orderly rather than frenetic. The macro correlation trade is working.

The weakness in the bullish corporate narrative comes down to specifics: Strategy's $75,385 average cost basis is 18% above current spot. IREN's 2027 target of 1.2 GW committed to Microsoft is capital that will not flow toward hash rate. Healthcare-firm treasuries built on Bitcoin promises dissolved on contact with a sub-$4 million funding gap.

Our read: the asset is performing; the corporate playbook around it is more fragile than the narrative infrastructure admits. Watch the $68,000-$70,000 zone – that is where Strategy's cost basis plus a plausible reentry premium converges. If price approaches that range and Strategy resumes purchases, the pause becomes tactical rather than structural. If BTC rallies past $70,000 without renewed corporate buying, the gap between price and institutional conviction becomes the story that matters.

FAQ

Why did Strategy raise $334M but not buy any Bitcoin?

According to filings covered by CoinDesk, the proceeds went toward STRC dividends, a preferred-share buyback, and building a dollar reserve that now stands at $4.8 billion – not toward adding to the company's 840,447 BTC position.

Is IREN leaving Bitcoin mining entirely?

IREN is pivoting its capacity focus toward AI cloud under a $9.7 billion Microsoft deal, targeting 1.2 GW of AI cloud by 2027, which represents a clear shift away from Bitcoin mining as its primary revenue driver, though it has not announced a full exit from mining.

What happened to the healthcare company's Bitcoin treasury?

The Nasdaq-listed healthcare data firm sold its entire Bitcoin position after reporting a $3.41 million working-capital deficit, with equity issuance identified as its clearest funding path – demonstrating that operationally stressed companies often cannot hold Bitcoin through downturns regardless of stated conviction.

This article is for educational purposes and is not investment advice. Cryptocurrencies carry high risk. Only trade with funds you can afford to lose.

CoinMagnetic

CoinMagnetic Team

Crypto investors since 2017. We trade with our own money and test every exchange ourselves.

Updated: August 2026

Follow our analysis on Telegram

We publish analysis, digests and forecasts on our Telegram channel.

Follow the channel

Related articles